Verona Pharma Plc ADR (VRNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VRNA | ARWR | AXSM | ||
| Company | Verona Pharma Plc ADR | Arrowhead Pharma | Axsome Thera | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 106.85 | 63.35 | 170.48 | ||
| High | 106.93 | 64.86 | 174.81 | ||
| Low | 106.81 | 62.70 | 169.88 | ||
| Latest | 106.91 | 62.92 | 171.78 | ||
| Change | +0.12 | +0.22 | +2.76 | ||
| % Change | +0.11% | +0.35% | +1.63% | ||
| Volume | 1,871,900 | 1,677,800 | 604,200 | ||
| 20-Day Average Volume | 1,504,320 | 2,609,815 | 583,115 | ||
| Previous Close | 106.79 | 62.70 | 169.02 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 106.48 | 58.60 | 160.83 | ||
| 20-Day Raw Stochastic | 98.26% | 76.63% | 86.55% | ||
| 20-Day Relative Strength | 70.52 | 54.23 | 55.27 | ||
| Weighted Alpha | +201.62 | +313.90 | +72.18 | ||
| Today's Opinion | 100% Buy | 64% Buy | 48% Buy | ||
| Previous Opinion | 100% Buy | 48% Buy | 40% Buy | ||
| Last Month's Opinion | 100% Buy | 56% Buy | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.28% since 09/29/25 | +3.54% since 03/25/26 | +6.18% since 03/25/26 | ||
| Low | 106.61 on 09/30/25 | 55.40 on 03/26/26 | 155.00 on 03/30/26 | ||
| High | 106.93 on 10/06/25 | 64.86 on 04/01/26 | 174.81 on 04/01/26 | ||
| 1-Month | |||||
| %Chg | +0.56% since 09/05/25 | -0.55% since 02/27/26 | +4.81% since 02/27/26 | ||
| Low | 105.78 on 09/19/25 | 54.02 on 03/13/26 | 152.28 on 03/24/26 | ||
| High | 106.93 on 10/06/25 | 67.15 on 03/03/26 | 174.81 on 04/01/26 | ||
| 3-Month | |||||
| %Chg | +16.80% since 07/03/25 | -5.23% since 12/31/25 | -5.95% since 12/31/25 | ||
| Low | 86.63 on 07/08/25 | 54.02 on 03/13/26 | 152.28 on 03/24/26 | ||
| High | 106.93 on 10/06/25 | 76.76 on 01/06/26 | 191.50 on 01/22/26 | ||
| 6-Month | |||||
| %Chg | +98.35% since 04/04/25 | +79.72% since 10/01/25 | +44.88% since 10/01/25 | ||
| Low | 47.20 on 04/07/25 | 34.47 on 10/02/25 | 117.30 on 10/08/25 | ||
| High | 106.93 on 10/06/25 | 76.76 on 01/06/26 | 191.50 on 01/22/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 8,748,446 | 8,780,006 | 8,645,878 | ||
| Shares Outstanding, K | 81,830 | 140,032 | 51,153 | ||
| Annual Sales | 42,280,000 | 829,450,000 | 638,500,000 | ||
| Annual Net Income | -173,420,000 | -1,630,000 | -183,170,000 | ||
| Last Quarter Sales | 103,140,000 | 264,030,000 | 196,000,000 | ||
| Last Quarter Net Income | 11,920,000 | 30,810,000 | -28,560,000 | ||
| 60-Month Beta | 0.05 | 1.23 | 0.43 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.13 on 08/06/25 | 0.22 on 02/05/26 | -0.71 on 02/23/26 | ||
| Latest Earnings Date | 11/03/25 | 05/11/26 | 05/04/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 37.68 | 0.00 | ||